Stereotactic body radiotherapy optimization to reduce the risk of carotid blowout syndrome using normal tissue complication probability objectives.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
May 2022
Historique:
revised: 14 01 2022
received: 15 09 2021
accepted: 02 02 2022
pubmed: 24 2 2022
medline: 24 5 2022
entrez: 23 2 2022
Statut: ppublish

Résumé

To determine the possibility of further improving clinical stereotactic body radiotherapy (SBRT) plans using normal tissue complication probability (NTCP) objectives in order to minimize the risk for carotid blowout syndrome (CBOS). 10 patients with inoperable locally recurrent head and neck cancer, who underwent SBRT using CyberKnife were analyzed. For each patient, three treatment plans were examined: (1) cone-based without delineation of the ipsilateral internal carotid (clinical plan used to treat the patients); (2) cone-based with the carotid retrospectively delineated and spared; and (3) Iris-based with carotid sparing. The dose-volume histograms of the target and primary organs at risk were calculated. The three sets of plans were compared based on dosimetric and TCP/NTCP (tumor control and normal tissue complication probabilities) metrics. For the NTCP values of carotid, the relative seriality model was used with the following parameters: D Across the 10 patient plans, the average TCP did not significantly change when the plans were re-optimized to spare the carotid. The estimated risk of CBOS was significantly decreased in the re-optimized plans, by 14.9% ± 7.4% for the cone-based plans and 17.7% ± 7.1% for the iris-based plans (p = 0.002 for both). The iris-based plans had significant (p = 0.02) reduced CBOS risk and delivery time (20.1% ± 7.4% time reduction, p = 0.002) compared to the cone-based plans. A significant improvement in the quality of the clinical plans could be achieved through the delineation of the internal carotids and the use of more modern treatment delivery modalities. In this way, for the same target coverage, a significant reduction in the risk of CBOS could be achieved. The range of risk reduction varied depending on the proximity of carotid artery to the target.

Identifiants

pubmed: 35194924
doi: 10.1002/acm2.13563
pmc: PMC9121056
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13563

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Radiat Oncol. 2013 Oct 18;8:242
pubmed: 24139288
J Clin Oncol. 2015 Aug 10;33(23):e97-8
pubmed: 24687819
J Appl Clin Med Phys. 2022 May;23(5):e13563
pubmed: 35194924
Phys Med Biol. 2009 Sep 21;54(18):5359-80
pubmed: 19687567
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):731-40
pubmed: 17379449
Head Neck. 2005 Aug;27(8):653-8
pubmed: 16035097
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1348-55
pubmed: 19117695
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):605-9
pubmed: 7790245
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1067-73
pubmed: 17967302
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):948-58
pubmed: 12095562
J Clin Oncol. 2008 Dec 1;26(34):5518-23
pubmed: 18936479
Med Phys. 2018 Oct;45(10):4754-4762
pubmed: 30102783
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):104-9
pubmed: 20675075
Acta Oncol. 1999;38(6):787-98
pubmed: 10522770
Clin Exp Otorhinolaryngol. 2016 Dec;9(4):287-297
pubmed: 27337948
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1532-7
pubmed: 19306749
Semin Oncol. 2008 Jun;35(3):251-61
pubmed: 18544440
Int J Radiat Biol. 1992 Aug;62(2):249-62
pubmed: 1355519
Laryngoscope. 1995 Oct;105(10):1086-92
pubmed: 7564841
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1493-500
pubmed: 19464819
Int J Radiat Oncol Biol Phys. 1992;23(2):271-80
pubmed: 1587746
J Appl Clin Med Phys. 2020 May;21(5):38-47
pubmed: 32212374
Head Neck. 2005 Mar;27(3):182-6
pubmed: 15627262

Auteurs

Gregory Szalkowski (G)

Department of Radiation Oncology, University of North Carolina, North Carolina, Chapel Hill, USA.

Zeynep Karakas (Z)

Department of Radiation Oncology, University of North Carolina, North Carolina, Chapel Hill, USA.

Mustafa Cengiz (M)

Faculty of Medicine, Department of Radiation Oncology, Hacettepe University, Sihhiye, Ankara, Turkey.

Eric Schreiber (E)

Department of Radiation Oncology, University of North Carolina, North Carolina, Chapel Hill, USA.

Shiva Das (S)

Department of Radiation Oncology, University of North Carolina, North Carolina, Chapel Hill, USA.

Gozde Yazici (G)

Faculty of Medicine, Department of Radiation Oncology, Hacettepe University, Sihhiye, Ankara, Turkey.

Gokhan Ozyigit (G)

Faculty of Medicine, Department of Radiation Oncology, Hacettepe University, Sihhiye, Ankara, Turkey.

Panayiotis Mavroidis (P)

Department of Radiation Oncology, University of North Carolina, North Carolina, Chapel Hill, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH